Log In
Print
BCIQ
Print
Print this Print this
 

Daliresp, Daxas, Roflumilast (APTA-2217)

  Manage Alerts
Collapse Summary General Information
Company Takeda Pharmaceutical Co. Ltd.
DescriptionNon-steroidal phosphodiesterase-4 (PDE-4) inhibitor
Molecular Target Phosphodiesterase-4 (PDE-4)
Mechanism of ActionPhosphodiesterase-4 (PDE-4) inhibitor
Latest Stage of DevelopmentMarketed
IndicationChronic obstructive pulmonary disease (COPD)
Partner

Forest Laboratories Inc.; Merck & Co. Inc.; Mitsubishi Tanabe Pharma Corp.
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today